Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges.

Bagno L, Hatzistergos KE, Balkan W, Hare JM.

Mol Ther. 2018 Jul 5;26(7):1610-1623. doi: 10.1016/j.ymthe.2018.05.009. Epub 2018 May 25. Review.

PMID:
29807782
2.

Preclinical Studies of Stem Cell Therapy for Heart Disease.

Tompkins BA, Balkan W, Winkler J, Gyöngyösi M, Goliasch G, Fernández-Avilés F, Hare JM.

Circ Res. 2018 Mar 30;122(7):1006-1020. doi: 10.1161/CIRCRESAHA.117.312486. Review.

PMID:
29599277
3.

Simulated Microgravity Impairs Cardiac Autonomic Neurogenesis from Neural Crest Cells.

Hatzistergos KE, Jiang Z, Valasaki K, Takeuchi LM, Balkan W, Atluri P, Saur D, Seidler B, Tsinoremas N, DiFede DL, Hare JM.

Stem Cells Dev. 2018 Jun 15;27(12):819-830. doi: 10.1089/scd.2017.0265. Epub 2018 Mar 20.

PMID:
29336212
4.

A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.

Natsumeda M, Florea V, Rieger AC, Tompkins BA, Banerjee MN, Golpanian S, Fritsch J, Landin AM, Kashikar ND, Karantalis V, Loescher VY, Hatzistergos KE, Bagno L, Sanina C, Mushtaq M, Rodriguez J, Rosado M, Wolf A, Collon K, Vincent L, Kanelidis AJ, Schulman IH, Mitrani R, Heldman AW, Balkan W, Hare JM.

J Am Coll Cardiol. 2017 Nov 14;70(20):2504-2515. doi: 10.1016/j.jacc.2017.09.036.

PMID:
29145950
6.

What Is the Future of Cell-Based Therapy for Acute Myocardial Infarction.

Tompkins BA, Natsumeda M, Balkan W, Hare JM.

Circ Res. 2017 Jan 20;120(2):252-255. doi: 10.1161/CIRCRESAHA.116.310340. No abstract available.

7.

Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical Trials.

Kanelidis AJ, Premer C, Lopez J, Balkan W, Hare JM.

Circ Res. 2017 Mar 31;120(7):1139-1150. doi: 10.1161/CIRCRESAHA.116.309819. Epub 2016 Dec 28.

8.

Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine.

Kulandavelu S, Karantalis V, Fritsch J, Hatzistergos KE, Loescher VY, McCall F, Wang B, Bagno L, Golpanian S, Wolf A, Grenet J, Williams A, Kupin A, Rosenfeld A, Mohsin S, Sussman MA, Morales A, Balkan W, Hare JM.

J Am Coll Cardiol. 2016 Dec 6;68(22):2454-2464. doi: 10.1016/j.jacc.2016.09.925.

9.

Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways.

Hatzistergos KE, Saur D, Seidler B, Balkan W, Breton M, Valasaki K, Takeuchi LM, Landin AM, Khan A, Hare JM.

Circ Res. 2016 Sep 30;119(8):921-30. doi: 10.1161/CIRCRESAHA.116.309281. Epub 2016 Aug 1.

10.

Is the regulation of SIRT1 by miRNA-34a the key to mesenchymal stem cell survival?

Bellio MA, Balkan W, Hare JM, Schulman IH.

Ann Transl Med. 2016 Jun;4(12):243. doi: 10.21037/atm.2016.05.45. No abstract available.

11.

GSNOR Deficiency Enhances In Situ Skeletal Muscle Strength, Fatigue Resistance, and RyR1 S-Nitrosylation Without Impacting Mitochondrial Content and Activity.

Moon Y, Cao Y, Zhu J, Xu Y, Balkan W, Buys ES, Diaz F, Kerrick WG, Hare JM, Percival JM.

Antioxid Redox Signal. 2017 Feb 1;26(4):165-181. doi: 10.1089/ars.2015.6548. Epub 2016 Aug 19.

12.

Mesenchymal Stem Cells in Cardiology.

White IA, Sanina C, Balkan W, Hare JM.

Methods Mol Biol. 2016;1416:55-87. doi: 10.1007/978-1-4939-3584-0_4.

13.

Cell Therapy Augments Myocardial Perfusion and Improves Quality of Life in Patients With Refractory Angina.

Florea V, Balkan W, Schulman IH, Hare JM.

Circ Res. 2016 Mar 18;118(6):911-5. doi: 10.1161/CIRCRESAHA.116.308409. No abstract available.

14.

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.

Tompkins B, Balkan W, Hare JM.

EBioMedicine. 2015 Nov 26;2(12):1838-9. doi: 10.1016/j.ebiom.2015.11.043. eCollection 2015 Dec. No abstract available.

15.

Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.

Karantalis V, Suncion-Loescher VY, Bagno L, Golpanian S, Wolf A, Sanina C, Premer C, Kanelidis AJ, McCall F, Wang B, Balkan W, Rodriguez J, Rosado M, Morales A, Hatzistergos K, Natsumeda M, Margitich I, Schulman IH, Gomes SA, Mushtaq M, DiFede DL, Fishman JE, Pattany P, Zambrano JP, Heldman AW, Hare JM.

J Am Coll Cardiol. 2015 Nov 3;66(18):1990-1999. doi: 10.1016/j.jacc.2015.08.879.

16.

cKit+ cardiac progenitors of neural crest origin.

Hatzistergos KE, Takeuchi LM, Saur D, Seidler B, Dymecki SM, Mai JJ, White IA, Balkan W, Kanashiro-Takeuchi RM, Schally AV, Hare JM.

Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13051-6. doi: 10.1073/pnas.1517201112. Epub 2015 Oct 5.

17.

S-nitrosylation and MSC-mediated body composition.

Cao Y, Balkan W, Hare JM.

Oncotarget. 2015 Oct 6;6(30):28517-8. doi: 10.18632/oncotarget.5672. No abstract available.

18.

Sympathetic Reinnervation Is Required for Mammalian Cardiac Regeneration.

White IA, Gordon J, Balkan W, Hare JM.

Circ Res. 2015 Dec 4;117(12):990-4. doi: 10.1161/CIRCRESAHA.115.307465. Epub 2015 Sep 14.

19.

Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection.

Chung HS, Murray CI, Venkatraman V, Crowgey EL, Rainer PP, Cole RN, Bomgarden RD, Rogers JC, Balkan W, Hare JM, Kass DA, Van Eyk JE.

Circ Res. 2015 Oct 23;117(10):846-57. doi: 10.1161/CIRCRESAHA.115.307336. Epub 2015 Sep 3.

20.

S-Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial Infarction.

Hatzistergos KE, Paulino EC, Dulce RA, Takeuchi LM, Bellio MA, Kulandavelu S, Cao Y, Balkan W, Kanashiro-Takeuchi RM, Hare JM.

J Am Heart Assoc. 2015 Jul 15;4(7). pii: e001974. doi: 10.1161/JAHA.115.001974.

21.

Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.

Premer C, Blum A, Bellio MA, Schulman IH, Hurwitz BE, Parker M, Dermarkarian CR, DiFede DL, Balkan W, Khan A, Hare JM.

EBioMedicine. 2015 Mar 28;2(5):467-75. doi: 10.1016/j.ebiom.2015.03.020. eCollection 2015 May.

22.

Regulation of oxygen delivery to the body via hypoxic vasodilation.

Kulandavelu S, Balkan W, Hare JM.

Proc Natl Acad Sci U S A. 2015 May 19;112(20):6254-5. doi: 10.1073/pnas.1506523112. Epub 2015 May 5. No abstract available.

23.

Growth hormone-releasing hormone agonists reduce myocardial infarct scar in swine with subacute ischemic cardiomyopathy.

Bagno LL, Kanashiro-Takeuchi RM, Suncion VY, Golpanian S, Karantalis V, Wolf A, Wang B, Premer C, Balkan W, Rodriguez J, Valdes D, Rosado M, Block NL, Goldstein P, Morales A, Cai RZ, Sha W, Schally AV, Hare JM.

J Am Heart Assoc. 2015 Mar 31;4(4). pii: e001464. doi: 10.1161/JAHA.114.001464.

24.

S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis.

Cao Y, Gomes SA, Rangel EB, Paulino EC, Fonseca TL, Li J, Teixeira MB, Gouveia CH, Bianco AC, Kapiloff MS, Balkan W, Hare JM.

J Clin Invest. 2015 Apr;125(4):1679-91. doi: 10.1172/JCI73780. Epub 2015 Mar 23.

25.

Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients.

Golpanian S, El-Khorazaty J, Mendizabal A, DiFede DL, Suncion VY, Karantalis V, Fishman JE, Ghersin E, Balkan W, Hare JM.

J Am Coll Cardiol. 2015 Jan 20;65(2):125-32. doi: 10.1016/j.jacc.2014.10.040.

26.

Allogeneic cell therapy: a new paradigm in therapeutics.

Karantalis V, Schulman IH, Balkan W, Hare JM.

Circ Res. 2015 Jan 2;116(1):12-5. doi: 10.1161/CIRCRESAHA.114.305495. No abstract available.

27.

Clinical research skills development program in cell-based regenerative medicine.

Schulman IH, Suncion V, Karantalis V, Balkan W, Hare JM; Cardiovascular Cell Therapy Research Network.

Stem Cells Transl Med. 2015 Feb;4(2):118-22. doi: 10.5966/sctm.2014-0144. Epub 2014 Dec 29.

28.

Interaction between neuronal nitric oxide synthase signaling and temperature influences sarcoplasmic reticulum calcium leak: role of nitroso-redox balance.

Dulce RA, Mayo V, Rangel EB, Balkan W, Hare JM.

Circ Res. 2015 Jan 2;116(1):46-55. doi: 10.1161/CIRCRESAHA.116.305172. Epub 2014 Oct 17.

29.

MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.

Patel A, Burton DG, Halvorsen K, Balkan W, Reiner T, Perez-Stable C, Cohen A, Munoz A, Giribaldi MG, Singh S, Robbins DJ, Nguyen DM, Rai P.

Oncogene. 2015 May 14;34(20):2586-96. doi: 10.1038/onc.2014.195. Epub 2014 Jul 14.

30.

S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells.

Gomes SA, Rangel EB, Premer C, Dulce RA, Cao Y, Florea V, Balkan W, Rodrigues CO, Schally AV, Hare JM.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2834-9. doi: 10.1073/pnas.1220185110. Epub 2013 Jan 3.

31.

Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair.

Oskouei BN, Lamirault G, Joseph C, Treuer AV, Landa S, Da Silva J, Hatzistergos K, Dauer M, Balkan W, McNiece I, Hare JM.

Stem Cells Transl Med. 2012 Feb;1(2):116-24. doi: 10.5966/sctm.2011-0015. Epub 2012 Feb 7.

32.

Cell-based therapy for prevention and reversal of myocardial remodeling.

Karantalis V, Balkan W, Schulman IH, Hatzistergos KE, Hare JM.

Am J Physiol Heart Circ Physiol. 2012 Aug 1;303(3):H256-70. doi: 10.1152/ajpheart.00221.2012. Epub 2012 May 25. Review.

33.

Advances in cell-based therapy for peripheral vascular disease.

Blum A, Balkan W, Hare JM.

Atherosclerosis. 2012 Aug;223(2):269-77. doi: 10.1016/j.atherosclerosis.2012.03.017. Epub 2012 Mar 23. Review.

PMID:
22494624
34.

Wnt signalling: a mediator of the heart-bone marrow axis after myocardial injury?

Dulce RA, Balkan W, Hare JM, Schulman IH.

Eur Heart J. 2012 Aug;33(15):1861-3. doi: 10.1093/eurheartj/ehr395. Epub 2011 Dec 23. No abstract available.

35.

A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer.

Rao S, Lyons LS, Fahrenholtz CD, Wu F, Farooq A, Balkan W, Burnstein KL.

Oncogene. 2012 Feb 9;31(6):716-27. doi: 10.1038/onc.2011.273. Epub 2011 Jul 18.

36.

Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-myocardial infarction.

Kanashiro-Takeuchi RM, Takeuchi LM, Hatzistergos K, Quevedo H, Selem SM, Treuer AV, Premer C, Balkan W, Margitich I, Song Y, Hu Q, Hare JM.

Clin Transl Sci. 2011 Jun;4(3):168-74. doi: 10.1111/j.1752-8062.2011.00278.x.

37.

Retinoic acid inhibits NFATc1 expression and osteoclast differentiation.

Balkan W, Rodríguez-Gonzalez M, Pang M, Fernandez I, Troen BR.

J Bone Miner Metab. 2011 Nov;29(6):652-61. doi: 10.1007/s00774-011-0261-0. Epub 2011 Mar 8.

PMID:
21384111
38.

Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.

Balkan W, Martinez AF, Fernandez I, Rodriguez MA, Pang M, Troen BR.

Gene. 2009 Oct 15;446(2):90-8. doi: 10.1016/j.gene.2009.06.013. Epub 2009 Jun 27.

PMID:
19563866
39.

Body surface area prediction in normal, hypermuscular, and obese mice.

Cheung MC, Spalding PB, Gutierrez JC, Balkan W, Namias N, Koniaris LG, Zimmers TA.

J Surg Res. 2009 May 15;153(2):326-31. doi: 10.1016/j.jss.2008.05.002. Epub 2008 Jun 4.

PMID:
18952236
40.

Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer.

Lyons LS, Rao S, Balkan W, Faysal J, Maiorino CA, Burnstein KL.

Mol Endocrinol. 2008 Mar;22(3):597-608. Epub 2007 Dec 13.

41.

AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.

Pang M, Martinez AF, Fernandez I, Balkan W, Troen BR.

Gene. 2007 Nov 15;403(1-2):151-8. Epub 2007 Aug 25.

PMID:
17897792
42.

The nucleoporin Nup96 is required for proper expression of interferon-regulated proteins and functions.

Faria AM, Levay A, Wang Y, Kamphorst AO, Rosa ML, Nussenzveig DR, Balkan W, Chook YM, Levy DE, Fontoura BM.

Immunity. 2006 Mar;24(3):295-304.

43.

Androgen-induced mineralization by MC3T3-E1 osteoblastic cells reveals a critical window of hormone responsiveness.

Balkan W, Burnstein KL, Schiller PC, Perez-Stable C, D'Ippolito G, Howard GA, Roos BA.

Biochem Biophys Res Commun. 2005 Mar 18;328(3):783-9.

PMID:
15694414
44.

RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells.

Pang M, Martinez AF, Jacobs J, Balkan W, Troen BR.

Biochem Biophys Res Commun. 2005 Mar 18;328(3):756-63.

PMID:
15694411
45.

Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells.

D'Ippolito G, Schiller PC, Perez-stable C, Balkan W, Roos BA, Howard GA.

Bone. 2002 Aug;31(2):269-75.

PMID:
12151078
46.

Gap-junctional communication is required for the maturation process of osteoblastic cells in culture.

Schiller PC, D'Ippolito G, Balkan W, Roos BA, Howard GA.

Bone. 2001 Apr;28(4):362-9.

PMID:
11336916
47.

Gap-junctional communication mediates parathyroid hormone stimulation of mineralization in osteoblastic cultures.

Schiller PC, D'Ippolito G, Balkan W, Roos BA, Howard GA.

Bone. 2001 Jan;28(1):38-44.

PMID:
11165941
48.

Testes exhibit elevated expression of calcitonin gene-related peptide receptor component protein.

Balkan W, Oates EL, Howard GA, Roos BA.

Endocrinology. 1999 Mar;140(3):1459-69.

PMID:
10067875
49.
50.

Calcitonin gene-related peptide (CGRP) in the developing mouse limb.

Bidegain M, Roos BA, Hill EL, Howard GA, Balkan W.

Endocr Res. 1995 Nov;21(4):743-55.

PMID:
8582325

Supplemental Content

Loading ...
Support Center